» Authors » Hadeel Almanea

Hadeel Almanea

Explore the profile of Hadeel Almanea including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 53
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Maddirevula S, Shagrani M, Ji A, Horne C, Young S, Mather L, et al.
Genet Med . 2024 Aug; 26(11):101231. PMID: 39132680
Purpose: Pediatric cholestasis is the phenotypic expression of clinically and genetically heterogeneous disorders of bile acid synthesis and flow. Although a growing number of monogenic causes of pediatric cholestasis have...
2.
Elashwah A, Alsuhaibani A, Abduljabbar A, Alsanea N, Alhomoud S, Ashari L, et al.
J Gastrointest Cancer . 2022 Dec; 54(3):927-936. PMID: 36525233
Purpose: Evaluating the outcome of pre-operative simultaneous integrated boost volumetric modulated arc therapy (SIB-VMAT) concomitant with capecitabine in patients diagnosed with locally advanced rectal cancer (LARC) at King Faisal Specialist...
3.
Shagrani M, Kumar K, Baker A, Al-Awwami M, Alhussaini H, Almanea H, et al.
Transplant Direct . 2022 Dec; 8(12):e1353. PMID: 36479277
Methods: From November 2010 to June 2015, 176 children aged 0.2-to18 y were transplanted in the King Faisal Specialist Hospital and Research Center. Out of those, 19 children were transplanted...
4.
Aljubran A, Badran A, Alrowaily M, Raef H, Alzahrani A, Almuhaideb A, et al.
Cancer Biother Radiopharm . 2022 Nov; 39(2):164-168. PMID: 36342790
Both everolimus and peptide receptor radionuclide therapy (PRRT) are approved as monotherapies for advanced neuroendocrine tumors (NETs). Research in animal models showed synergism between the two treatment modalities. This study...
5.
Bazarbashi S, Elshenawy M, Badran A, Aljubran A, Alzahrani A, Almanea H, et al.
Cancer Med . 2022 Feb; 11(10):2056-2066. PMID: 35146939
Introduction: Gemcitabine is a well-known radiosensitizer. Herein, we tested the efficacy and toxicity of preoperative concurrent infusional gemcitabine and radiotherapy in locally advanced rectal cancer. Patients And Methods: This was...
6.
Abouzied M, Fathala A, Almuhaideb A, Almanea H, Al-Sugair A, Alskaff R, et al.
Radiol Case Rep . 2021 Jan; 16(3):550-554. PMID: 33384755
A 69-year-old male patient who had a history of well-differentiated hepatocellular carcinoma (HCC) post right hepatectomy presented a year later with iron-deficiency anemia. His anemia work-up included upper endoscopy that...
7.
Alrajhi A, Alotaibi J, Alghamdi A, Almanea H, Alsebayel M, Al-Meshari K, et al.
Transpl Infect Dis . 2019 Nov; 22(1):e13212. PMID: 31715063
Objectives: Mycobacterium tuberculosis DNA has been detected in multiple organs in people without active tuberculosis or a history of tuberculosis. Molecular testing for metabolic activity has suggested that M tuberculosis...
8.
Kumar K, Almanea H, Broering D, Shagrani M
Transplant Proc . 2019 Aug; 51(9):3147-3149. PMID: 31371215
Background: Fibrocystic liver-kidney disease is caused by a group of rare and genetically diverse disorders that are associated with kidney cysts or dysplasia and ductal plate malformation in the liver....
9.
Alsuhaibani A, Elashwah A, Mahmood R, Abduljabbar A, Alhomoud S, Ashari L, et al.
J Gastrointest Cancer . 2018 Jul; PMID: 30006679
Purpose: Assess feasibility-rate of PCR, short-term toxicity after neoadjuvant concurrent chemoradiation (NACRT) delivered via simultaneous integrated boost (SIB) using volumetric modulated arc therapy (VMAT) technique for locally advanced rectal cancer....
10.
Siraj A, Bu R, Prabhakaran S, Bavi P, Beg S, Al Hazmi M, et al.
Mol Cancer . 2014 Jul; 13:168. PMID: 25005754
Background: Recent studies emphasize the role of BRAF as a genetic marker for prediction, prognosis and risk stratification in colorectal cancer. Earlier studies have reported the incidence of BRAF mutations...